Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region - PubMed
5 hours ago
- #Asia-Pacific
- #health burden
- #metabolic diseases
- The study analyzes the burden of metabolic diseases in the Asia-Pacific region from 1990 to 2023, with forecasts to 2030.
- High systolic blood pressure (SBP) accounted for the largest burden in 2023 (~138 million DALYs; 6.27 million deaths).
- Other significant contributors include high BMI (~55 million DALYs), high LDL cholesterol (~53 million DALYs), T2DM (~49 million DALYs), and MASLD (~1.26 million DALYs).
- From 1990 to 2023, total DALYs increased 1.7- to 3.7-fold, with the highest burdens in China, India, and Indonesia.
- Projections suggest continued rises in metabolic disease burdens, except for MASLD, with high SBP remaining dominant.
- The findings highlight the need for coordinated global actions to address metabolic conditions and support UN 2030 health goals.